1. Safety of Kidney Transplantation from Donors with HIV.
- Author
-
Durand, Christine, Massie, Allan, Florman, Sander, Liang, Tao, Rana, Meenakshi, Friedman-Moraco, Rachel, Gilbert, Alexander, Stock, Peter, Mehta, Sapna, Mehta, Shikha, Stosor, Valentina, Pereira, Marcus, Morris, Michele, Hand, Jonathan, Aslam, Saima, Malinis, Maricar, Haidar, Ghady, Small, Catherine, Santos, Carlos, Schaenman, Joanna, Baddley, John, Wojciechowski, David, Blumberg, Emily, Ranganna, Karthik, Adebiyi, Oluwafisayo, Elias, Nahel, Castillo-Lugo, Jose, Giorgakis, Emmanouil, Apewokin, Senu, Brown, Diane, Ostrander, Darin, Eby, Yolanda, Desai, Niraj, Naqvi, Fizza, Bagnasco, Serena, Watson, Natasha, Brittain, Erica, Odim, Jonah, Redd, Andrew, Tobian, Aaron, and Segev, Dorry
- Subjects
Female ,Humans ,Male ,Middle Aged ,Breakthrough Infections ,Graft Rejection ,Graft Survival ,HIV Infections ,Kidney Transplantation ,Postoperative Complications ,Tissue and Organ Procurement ,Tissue Donors ,Kidney Failure ,Chronic - Abstract
BACKGROUND: Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ Policy Equity Act and is currently approved for research only. The Department of Health and Human Services is considering expanding the procedure to clinical practice, but data are limited to small case series that did not include donors without HIV as controls. METHODS: In an observational study conducted at 26 U.S. centers, we compared transplantation of kidneys from deceased donors with HIV and donors without HIV to recipients with HIV. The primary outcome was a safety event (a composite of death from any cause, graft loss, serious adverse event, HIV breakthrough infection, persistent failure of HIV treatment, or opportunistic infection), assessed for noninferiority (margin for the upper bound of the 95% confidence interval, 3.00). Secondary outcomes included overall survival, survival without graft loss, rejection, infection, cancer, and HIV superinfection. RESULTS: We enrolled 408 transplantation candidates, of whom 198 received a kidney from a deceased donor; 99 received a kidney from a donor with HIV and 99 from a donor without HIV. The adjusted hazard ratio for the composite primary outcome was 1.00 (95% confidence interval [CI], 0.73 to 1.38), which showed noninferiority. The following secondary outcomes were similar whether the donor had HIV or not: overall survival at 1 year (94% vs. 95%) and 3 years (85% vs. 87%), survival without graft loss at 1 year (93% vs. 90%) and 3 years (84% vs. 81%), and rejection at 1 year (13% vs. 21%) and 3 years (21% vs. 24%). The incidence of serious adverse events, infections, surgical or vascular complications, and cancer was similar in the groups. The incidence of HIV breakthrough infection was higher among recipients of kidneys from donors with HIV (incidence rate ratio, 3.14; 95%, CI, 1.02 to 9.63), with one potential HIV superinfection among the 58 recipients in this group with sequence data and no persistent failures of HIV treatment. CONCLUSIONS: In this observational study of kidney transplantation in persons with HIV, transplantation from donors with HIV appeared to be noninferior to that from donors without HIV. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT03500315.).
- Published
- 2024